PEAK6 Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-15,000
Closed -$294K 4546
2018
Q1
$294K Sell
15,000
-159,400
-91% -$3.09M ﹤0.01% 3055
2017
Q4
$3.53M Buy
174,400
+69,900
+67% +$1.29M 0.02% 1023
2017
Q3
$1.81M Buy
+104,500
New +$1.42M 0.01% 1473
2016
Q1
Sell
-275,400
Closed -$4.77M 4638
2015
Q4
$4.77M Sell
275,400
-1,700
-0.6% -$27.1K 0.03% 753
2015
Q3
$3.72M Sell
277,100
-187,900
-40% -$3.77M 0.02% 1102
2015
Q2
$10.5M Buy
465,000
+255,000
+121% +$4.48M 0.06% 412
2015
Q1
$3M Buy
+210,000
New +$3.03M 0.02% 984
2014
Q4
Sell
-9,200
Closed -$84K 4830
2014
Q3
$84K Buy
+9,200
New +$87.6K ﹤0.01% 3888
2014
Q2
Sell
-74,500
Closed -$947K 4798
2014
Q1
$947K Sell
74,500
-2,700
-3% -$40.1K 0.01% 1915
2013
Q4
$1.16M Sell
77,200
-20,800
-21% -$268K 0.01% 1937
2013
Q3
$542K Buy
+98,000
New +$816K ﹤0.01% 2745

Other funds holding HALO

PEAK6 Group's HALO Position: Q2 2018 in Review

PEAK6 Group sold out of Halozyme (HALO) in Q2 2018, closing a stake of 11,390 shares — an estimated $223K sold.

PEAK6 Group first reported a position in HALO in Q1 2018 and held it in 1 quarter. The position peaked at $223K in Q1 2018. 193 funds tracked by Wall St. Rank hold HALO as of Q2 2018.

  • PEAK6 Group reported no remaining Halozyme position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 11,390 Halozyme shares in Q2 2018, an estimated $223K.
  • PEAK6 Group first reported a position in Halozyme in Q1 2018 and held it in 1 quarter.
  • PEAK6 Group's Halozyme position peaked at $223K in Q1 2018.
  • 193 funds tracked by Wall St. Rank held Halozyme as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.